journal article·2017-08

Tissue-engineered trachea regeneration using decellularized trachea matrix treated with laser micropore technique

Yong Xu, Dan Li, Zongqi Yin, Aijuan He, Miaomiao Lin, Gening Jiang, Xiao Song, Xuefei Hu, Yi Liu, Jinpeng Wang, Xiaoyun Wang, Liang Duan, Guangdong Zhou

Acta Biomaterialia· Volume 58
Publisher page

Abstract

Tissue-engineered trachea provides a promising approach for reconstruction of long segmental tracheal defects. However, a lack of ideal biodegradable scaffolds greatly restricts its clinical translation. Decellularized trachea matrix (DTM) is considered a proper scaffold for trachea cartilage regeneration owing to natural tubular structure, cartilage matrix components, and biodegradability. However, cell residual and low porosity of DTM easily result in immunogenicity and incomplete cartilage regeneration. To address these problems, a laser micropore technique (LMT) was applied in the current study to modify trachea sample porosity to facilitate decellular treatment and cell ingrowth. Decellularization processing demonstrated that cells in LMT treated samples were more easily removed compared with untreated native trachea. Furthermore, after optimizing the protocols of LMT and decellular treatments, the LMT-treated DTM (LDTM) could retain their original tubular shape with only mild extracellular matrix damage. After seeding with chondrocytes and culture in vitro for 8 weeks, the cell-LDTM constructs formed tubular cartilage with relatively homogenous cell distribution in both micropores and bilateral surfaces. In vivo results further confirmed that the constructs could form mature tubular cartilage with increased DNA and cartilage matrix contents, as well as enhanced mechanical strength, compared with native trachea. Collectively, these results indicate that LDTM is an ideal scaffold for tubular cartilage regeneration and, thus, provides a promising strategy for functional reconstruction of trachea cartilage. Statement of significance Lacking ideal biodegradable scaffolds greatly restricts development of tissue-engineered trachea. Decellularized trachea matrix (DTM) is considered a proper scaffold for trachea cartilage regeneration. However, cell residual and low porosity of DTM easily result in immunogenicity and incomplete cartilage regeneration. By laser micropore technique (LMT), the current study efficiently enhanced the porosity and decellularized efficacy of DTM. The LMT-treated DTM basically retained the original tubular shape with mild matrix damage. After chondrocyte seeding followed by in vitro culture and in vivo implantation, the constructs formed mature tubular cartilage with matrix content and mechanical strength similar to native trachea. The current study provides an ideal scaffold and a promising strategy for cartilage regeneration and functional reconstruction of trachea.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Tracheal and airway disorders · Tissue Engineering and Regenerative Medicine · Reconstructive Surgery and Microvascular Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (37)

Show source-provided references
1. Long-term functional reconstruction of segmental tracheal defect by pedicled tissue-engineered trachea in rabbits10.1016/j.biomaterials.2013.01.060 ↗
2. Tissue engineered airways: a prospects article10.1002/jcb.25512 ↗
3. Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study10.1016/S0140-6736(12)60737-5 ↗
4. Tissue-engineered tracheal transplantation10.1097/TP.0b013e3181cd4ad3 ↗
5. Tracheal matrices, obtained by a detergent-enzymatic method, support in vitro the adhesion of chondrocytes and tracheal epithelial cells10.1111/j.1432-2277.2005.00082.x ↗
6. Decellularized tracheal matrix scaffold for tissue engineering10.1097/PRS.0b013e31825dc084 ↗
7. Tissue engineered human tracheas for in vivo implantation10.1016/j.biomaterials.2010.08.005 ↗
8. Engineered whole organs and complex tissues10.1016/S0140-6736(12)60073-7 ↗
9. Clinical transplantation of a tissue-engineered airway10.1016/S0140-6736(08)61598-6 ↗
10. Trachea transplants test the limits10.1126/science.340.6130.266 ↗
11. The first tissue-engineered airway transplantation: 5-year follow-up results10.1016/S0140-6736(13)62033-4 ↗
12. Tissue engineering in the trachea10.1002/ar.22799 ↗
13. A sandwich model for engineering cartilage with acellular cartilage sheets and chondrocytes10.1016/j.biomaterials.2010.11.078 ↗
14. Hydrated xenogeneic decellularized tracheal matrix as a scaffold for tracheal reconstruction10.1016/j.biomaterials.2010.01.067 ↗
15. A cartilage ECM-derived 3-D porous acellular matrix scaffold for in vivo cartilage tissue engineering with PKH26-labeled chondrogenic bone marrow-derived mesenchymal stem cells10.1016/j.biomaterials.2008.01.037 ↗
16. Tissue-engineered tracheal reconstruction using chondrocyte seeded on a porcine cartilage-derived substance scaffold10.1016/j.ijporl.2013.10.014 ↗
17. Preparation of laser micropore porcine acellular dermal matrix for skin graft: an experimental study10.1016/j.burns.2006.08.039 ↗
18. Rapid biofabrication of tubular tissue constructs by centrifugal casting in a decellularized natural scaffold with laser-machined micropores10.1007/s10856-008-3590-3 ↗
19. Genipin cross-linked decellularized tracheal tubular matrix for tracheal tissue engineering applications10.1038/srep24429 ↗
20. The impact of low levels of collagen IX and pyridinoline on the mechanical properties of in vitro engineered cartilage10.1016/j.biomaterials.2008.10.042 ↗
21. The role of bFGF in down-regulating alpha-SMA expression of chondrogenically induced BMSCs and preventing the shrinkage of BMSC engineered cartilage10.1016/j.biomaterials.2011.03.020 ↗
22. Repair of porcine articular osteochondral defects in non-weightbearing areas with autologous bone marrow stromal cells10.1089/ten.2006.12.3209 ↗
23. A simplified method for the analysis of hydroxyproline in biological tissues10.1016/0009-9120(96)00003-6 ↗
24. Methods of tissue decellularization used for preparation of biologic scaffolds and in vivo relevance10.1016/j.ymeth.2015.03.005 ↗
25. Biocompatibility evaluation of tissue-engineered decellularized scaffolds for biomedical application10.1016/j.msec.2016.05.068 ↗
26. Effect of Er: YAG laser and organic matrix on porosity changes in human enamel10.1016/S0300-5712(03)00138-6 ↗
27. The effect of CO2 Laser on the permeability of dentinal tubules: a preliminary in vitro study10.1089/pho.2007.2060 ↗
28. Transmyocardial laser revascularization: clinical experience with twelve-month follow-up10.1016/S0022-5223(96)70339-2 ↗
29. Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease10.1016/S0022-5223(97)70221-6 ↗
30. Preliminary experiences in trachea scaffold tissue engineering with segmental organ decellularization10.1002/lary.25932 ↗
31. Prenatal tracheal reconstruction with a hybrid amniotic mesenchymal stem cells-engineered construct derived from decellularized airway10.1016/j.jpedsurg.2012.03.006 ↗
32. In vivo tissue-engineered allogenic trachea transplantation in rabbits: a preliminary report10.1007/s12015-014-9570-8 ↗
33. Functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors10.1016/j.biomaterials.2010.08.091 ↗
34. Transplantation of the cryopreserved tracheal allograft in growing rabbits10.1016/j.jpedsurg.2003.08.036 ↗
35. Insulin-like growth factor-i improves chondrogenesis of predifferentiated human umbilical cord mesenchymal stromal cells10.1002/jor.20848 ↗
36. Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells10.1016/j.jconrel.2007.11.006 ↗
37. Growth factor combination for chondrogenic induction from human mesenchymal stem cell10.1016/j.bbrc.2004.06.029 ↗